Value of Combined PET Imaging with [(18)F]FDG and [(68)Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [(177)Lu]Lu-PSMA-617 RLT

SIMPLE SUMMARY: Prostate-specific membrane antigen (PSMA) is regularly overexpressed in prostate cancer cells. Radioligand therapy (RLT) targeting PSMA has shown impressive results in recent years in treatment of metastatic castration-resistant prostate cancer (mCRPC). In some patients, however, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Khreish, Fadi, Ribbat, Kalle, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Hierlmeier, Ina, Linxweiler, Johannes, Schreckenberger, Mathias, Ezziddin, Samer, Rosar, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391978/
https://www.ncbi.nlm.nih.gov/pubmed/34439287
http://dx.doi.org/10.3390/cancers13164134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391978/
https://www.ncbi.nlm.nih.gov/pubmed/34439287
http://dx.doi.org/10.3390/cancers13164134

Ejemplares similares